New Cagrilintide data: reading the results critically
7 independently tested samples across 4 companies, and what the results say about Cagrilintide.
Study SummaryCagrilintide
Also known as: AM833
Moderate evidence
ClassLong-acting amylin analog
Research statusPhase 3 clinical trials
CategoryGLP-1 / incretin
Independent tests7
Studies indexed2
Companies tested 4
Overview
An amylin analog studied on its own and in combination with semaglutide, targeting satiety through a mechanism distinct from GLP-1.
Cagrilintide is classified as a long-acting amylin analog. Its current development status is: phase 3 clinical trials. Human trial data exists but is limited in size, duration or independence; conclusions should be held loosely.
The Peptide Institute tracks Cagrilintide because it is actively sold through research-compound and telehealth channels. Our interest is narrow and specific: what is actually in the vial, whether the label is accurate, and whether the sellers of it can document what they claim. We take no position on whether anyone should use it.
Independent Testing
Independently tested companies that sell Cagrilintide
Every company below was evaluated with product the Institute purchased anonymously and sent for third-party laboratory analysis. Ranked by Index Score™.
- Companies
- 4
- Samples
- 7
- Updated
- Aug 12, 2026
- 1 PureSci Labs Excellent Institute
Top Rated Cagrilintide99.3% average purity across 1 sample
Purity & Testing 99 Transparency 95 Samples 1 89 View company - 2 Lumen Research Supply Excellent
98.6% average purity across 2 samples
Purity & Testing 99 Transparency 80 Samples 2 89 View company - 3 Meridian Health Direct Excellent
96.1% average purity across 3 samples
Purity & Testing 97 Transparency 93 Samples 3 89 View company
Research & Studies
Studies library-
Immunogenicity and stability profile of Cagrilintide
Reports findings relevant to the primary claims made for Cagrilintide; sample size limits how far the result generalises.
-
Pharmacokinetics and tolerability of Cagrilintide in healthy adults
Adds to the Cagrilintide evidence base without resolving the central question of human efficacy.
Independent Testing
Testing databaseLaboratory verification of Cagrilintide products across the companies we index.
Cagrilintide Lumen Research Supply
Purity 98.7% Verified
Cagrilintide Lumen Research Supply
Purity 98.5% Verified
Cagrilintide Meridian Health Direct
Purity 97.0% Verified
Cagrilintide Meridian Health Direct
Purity 94.1% Verified
Cagrilintide Meridian Health Direct
Purity 97.3% Verified
Cagrilintide PureSci Labs
Purity 99.3% Verified
Cagrilintide Northwind Telehealth
Purity 93.8% Verified
Latest Coverage
Regulators signal closer attention to Cagrilintide supply channels
A close reading of the Cagrilintide evidence, without the marketing layer.
RegulationHow to evaluate a Cagrilintide certificate of analysis
Purity across our Cagrilintide samples ranged from 93.8% to 99.3%. Here is the context.
GuideCommunity Discussions
Forum 18 replies
24 replies
145 replies
7 replies
The Peptide Institute Weekly
Research. Testing. Regulation. No hype.
One email a week: new study summaries, the latest independent lab results, ranking movements, and regulatory developments that matter.
- New research, summarized in plain English
- Independent lab results as they publish
- Score and ranking movements